CPIX: Summary for Cumberland Pharmaceuticals Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 12:07am EST - Canadian Markets open in 9 hours and 23 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Cumberland Pharmaceuticals, Inc. (CPIX)

On Feb 9: 11.52 USD

0.11 (0.96%)

MORE ON CPIX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Cumberland Pharmaceuticals Inc. (NasdaqNM:CPIX) Delayed quote data

After Hours: 11.52 0.00 (0.00%) as of 4:34pm EST on 02/09/10

Last Trade:	11.52 USD
Trade Time:	Feb 9
Change:	0.11 (0.96%)
Prev Close:	11.41
Open:	11.47
Bid:	9.62 x 100
Ask:	N/A
1y Target Est:	20.67

Day's Range:	11.30 - 11.66
52wk Range:	11.30 - 17.75
Volume:	33,737
Avg Vol (3m):	41,384.1
Market Cap:	231.94M
P/E (ttm):	50.31
EPS (ttm):	0.23
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m

Free Annual Reports

Add CPIX to Portfolio

Download Data

HEADLINES

•	Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
	PRNewswire (Wed, Jan 20)

•	After A Sluggish Year, VCs Eye Improvement
	Investor's Business Daily (Fri, Jan 8)

•	Caldolor(R) Data to Be Presented During Critical Care Conference in Miami Beach, Florida on January 12, 2010
	PRNewswire (Tue, Jan 5)

•	The Worst IPOs Of 2009
	at Investopedia (Wed, Dec 16)

•	2009 Year End Strategy: Look at CEFs and IPOs
	at Seeking Alpha (Wed, Dec 16)

•	Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study
	PRNewswire (Tue, Dec 15)

•	Worst IPOs of 2009: Biggest Stock Flops
	at TheStreet.com (Tue, Dec 15)

•	Cumberland Pharma signs South Korea Caldolor deal
	AP (Wed, Dec 9)

•	Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
	PRNewswire (Wed, Dec 9)

•	New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting
	PRNewswire (Thu, Dec 3)

•	Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems
	PRNewswire (Tue, Dec 1)

More Headlines for CPIX...

ANALYST

EPS Est (next year) (Dec-09) :	0.20
EPS Est (in 2 years) (Dec-10) :	0.48
Avg Rec (current)*:	1.5
PEG Ratio:	0.79

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cumberland Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets.

Full Company Profile

Add to Portfolio

Email to a Friend

•